REQUEST A DEMO
Total
USD $0.00
Search more companies

Concord Drugs Ltd. (India)

Main Activities: Pharmaceutical and Medicine Manufacturing
Full name: Concord Drugs Ltd. Profile Updated: December 02, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English Download a sample report

Concord Drugs Ltd. ventures as a pharmaceutical company that manufactures Finished Pharmaceutical Formulations like Injectables, Tissue Bio-Adhesive, tablets, capsules and ophthalmic preparations and Ready-to-fill Pellets. Concord Drugs Ltd.'s office is located in Hyderabad.

Legal Address
Survey No.249,, , Brahmanpally Village
Hyderabad; Telangana; Postal Code: 501511

Contact Details: Purchase the Concord Drugs Ltd. report to view the information.

Website: http://www.concorddrugs.in

Basic Information
Total Employees:
Purchase the Concord Drugs Ltd. report to view the information.
Outstanding Shares:
Purchase the Concord Drugs Ltd. report to view the information.
Registered Capital:
Purchase the Concord Drugs Ltd. report to view the information.
Financial Auditors:
Purchase the Concord Drugs Ltd. report to view the information.
Incorporation Date:
1995
Key Executives
Purchase this report to view the information.
Executive Director & CFO
Purchase this report to view the information.
Independent Director
Purchase this report to view the information.
Independent Director
Purchase this report to view the information.
Non Executive Director
Purchase this report to view the information.
Managing Director
Ownership Details
Purchase this report to view the information.
54.39%
Purchase this report to view the information.
45.11%
Purchase this report to view the information.
0.5%
Purchase this report to view the information.
Company Performance
Financial values in the chart are available after Concord Drugs Ltd. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency INR. Absolute financial data is included in the purchased report.
Net sales revenue
30.18%
Total operating revenue
30.18%
Operating profit (EBIT)
-54.63%
EBITDA
-43.15%
Net Profit (Loss) for the Period
-93.88%
Total equity
7.3%
Operating Profit Margin (ROS)
-7.84%
Net Profit Margin
-5.2%
Return on Equity (ROE)
-4.96%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?